This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fonjungo, P. N.
Right arrow Articles by McBride, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fonjungo, P. N.
Right arrow Articles by McBride, J. S.

 Previous Article  |  Next Article 

Infection and Immunity, June 1999, p. 2975-2985, Vol. 67, No. 6
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

A Longitudinal Study of Human Antibody Responses to Plasmodium falciparum Rhoptry-Associated Protein 1 in a Region of Seasonal and Unstable Malaria Transmission

Peter N. Fonjungo,1,dagger Ibrahim M. Elhassan,2,3 David R. Cavanagh,1 Thor G. Theander,2 Lars Hviid,2 Cally Roper,1,4 David E. Arnot,1 and Jana S. McBride1,*

Institute of Cell, Animal and Population Biology, University of Edinburgh, Edinburgh EH9 3JT, Scotland1; Centre for Medical Parasitology at the Institute for Medical Microbiology and Immunology, University of Copenhagen and RHIMA Centre, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark2; Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan3; and Department of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine, London, England4

Received 26 October 1998/Returned for modification 15 December 1998/Accepted 26 March 1999

Rhoptry-associated protein 1 (RAP1) of Plasmodium falciparum is a nonpolymorphic merozoite antigen that is considered a potential candidate for a malaria vaccine against asexual blood stages. In this longitudinal study, recombinant RAP1 (rRAP1) proteins with antigenicity similar to that of P. falciparum-derived RAP1 were used to analyze antibody responses to RAP1 over a period of 4 years (1991 to 1995) of 53 individuals naturally exposed to P. falciparum malaria. In any 1 year during the study, between 23 and 39% of individuals who had malaria developed immunoglobulin G (IgG) antibodies detectable with at least one rRAP1 protein. However, the anti-RAP1 antibody responses were detected only during or shortly after clinical malarial infections. RAP1 antibody levels declined rapidly (within 1 to 2 months) following drug treatment of the infections. No anti-RAP1 antibodies were usually detected a few months after the end of malaria transmission, during the dry season, or by the start of the next malaria season. Thus, RAP1 IgG responses were very short-lived. The short duration of RAP1 antibody response may explain the apparent lack of response in a surprisingly high proportion of individuals after clinical malarial infections. For some individuals who experienced more than one malarial infection, a higher anti-RAP1 antibody response to subsequent infections than to earlier infections was observed. This suggested secondary responses to RAP1 and thus the development of immunological memory for RAP1.

* Corresponding author. Mailing address: Institute of Cell, Animal and Population Biology, University of Edinburgh, King's Buildings, West Mains Rd., Edinburgh EH9 3JT, Scotland. Phone: 44 131 650 5494. Fax: 44 131 667 3210. E-mail: JMCBRIDE{at}ed.ac.uk.

dagger Present address: HIV/Retrovirus Disease Branch, Centers for Disease Control and Prevention, Atlanta, Ga.

Infection and Immunity, June 1999, p. 2975-2985, Vol. 67, No. 6
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Nogueira, P. A., Piovesan Alves, F., Fernandez-Becerra, C., Pein, O., Rodrigues Santos, N., Pereira da Silva, L. H., Plessman Camargo, E., del Portillo, H. A. (2006). A Reduced Risk of Infection with Plasmodium vivax and Clinical Protection against Malaria Are Associated with Antibodies against the N Terminus but Not the C Terminus of Merozoite Surface Protein 1.. Infect. Immun. 74: 2726-2733 [Abstract] [Full Text]  
  • Singh, S., Soe, S., Roussilhon, C., Corradin, G., Druilhe, P. (2005). Plasmodium falciparum Merozoite Surface Protein 6 Displays Multiple Targets for Naturally Occurring Antibodies That Mediate Monocyte-Dependent Parasite Killing. Infect. Immun. 73: 1235-1238 [Abstract] [Full Text]  
  • Achtman, A. H., Khan, M., MacLennan, I. C. M., Langhorne, J. (2003). Plasmodium chabaudi chabaudi Infection in Mice Induces Strong B Cell Responses and Striking But Temporary Changes in Splenic Cell Distribution. J. Immunol. 171: 317-324 [Abstract] [Full Text]  
  • Wang, L., Richie, T. L., Stowers, A., Nhan, D. H., Coppel, R. L. (2001). Naturally Acquired Antibody Responses to Plasmodium falciparum Merozoite Surface Protein 4 in a Population Living in an Area of Endemicity in Vietnam. Infect. Immun. 69: 4390-4397 [Abstract] [Full Text]  
  • Cavanagh, D. R., Dobano, C., Elhassan, I. M., Marsh, K., Elhassan, A., Hviid, L., Khalil, E. A. T. G., Theander, T. G., Arnot, D. E., McBride, J. S. (2001). Differential Patterns of Human Immunoglobulin G Subclass Responses to Distinct Regions of a Single Protein, the Merozoite Surface Protein 1 of Plasmodium falciparum. Infect. Immun. 69: 1207-1211 [Abstract] [Full Text]  
  • Giha, H. A., Staalsoe, T., Dodoo, D., Elhassan, I. M., Roper, C., Satti, G. M. H., Arnot, D. E., Theander, T. G., Hviid, L. (1999). Nine-Year Longitudinal Study of Antibodies to Variant Antigens on the Surface of Plasmodium falciparum-Infected Erythrocytes. Infect. Immun. 67: 4092-4098 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»